What type of study is this?

This is a Cohort Study study (also classified as: Human Clinical Trial, Validation Study).

December 8, 2025BloodOpen Access

Area deprivation index independently predicts outcomes in IPSS-R higher-risk myelodysplastic syndromes at a major cancer center

View Full Paper

Ask AI

Bookmark

Authors

KSKoji SasakiThe University of Texas MD Anderson Cancer Center DFD. G. FoxThe University of Texas MD Anderson Cancer Center GMGuillermo Montalban‐BravoThe University of Texas MD Anderson Cancer Center

Discussion

Member takes

Implication

Retrospective analysis reveals the Area Deprivation Index predicts outcomes in higher-risk myelodysplastic syndromes, indicating health equity matters.

Key Points

Higher rates of acute myeloid leukemia transformation were found in patients with adverse area deprivation index quartiles.
Analysis of clinical characteristics showed that stem cell transplantation significantly differed across area deprivation quartiles.
Younger age and clinical trial participation were associated with improved overall survival in higher-risk myelodysplastic syndromes.
Total bilirubin and TP53 mutations were identified as adverse prognostic factors correlating with decreased overall survival.

Cite This Study

Sasaki et al. (2025) studied this question.

synapsesocial.com/papers/69362f3a4fa91c937236d3cc https://doi.org/10.1182/blood-2025-4634

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis reveals the Area Deprivation Index predicts outcomes in higher-risk myelodysplastic syndromes, indicating health equity matters.

Area deprivation index independently predicts outcomes in IPSS-R higher-risk myelodysplastic syndromes at a major cancer center

Discussion

Member takes

Implication

Key Points

Cite This Study

Area deprivation index independently predicts outcomes in IPSS-R higher-risk myelodysplastic syndromes at a major cancer center

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider